1 |
Jia B, Xia P, Dong J, Feng W, Wang W, Liu E, Jiang G, Qin Y. Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.1086908] [Reference Citation Analysis]
|
2 |
Yang Y, Zhang H, Huang S, Chu Q. KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration. J Clin Med 2023;12. [PMID: 36675641 DOI: 10.3390/jcm12020709] [Reference Citation Analysis]
|
3 |
Wang S, Jiang Y, Miao H, Fang Y, Jiang N, Yu Y, Ma P, Tang Q, Cui D, Fang H, Huang H, Fan Q, Sun C, Yu A, Miao S, Du J, Zhu J, Wang Y, Li N. Targeting rare tumors: new focus for clinical research in China. EMBO Mol Med 2023;15:e16415. [PMID: 36437781 DOI: 10.15252/emmm.202216415] [Reference Citation Analysis]
|
4 |
Gkountakos A, Mafficini A, Lou E, Malleo G, Salvia R, Calicchia M, Silvestris N, Racila E, Amin K, Veronese N, Brunetti O, Antonini P, Ingravallo G, Mattiolo P, Saponaro C, Nappo F, Simbolo M, Bariani E, Lonardi S, Fassan M, Milella M, Lawlor RT, Scarpa A, Luchini C. Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas. Hum Pathol 2022:S0046-8177(22)00184-8. [PMID: 35850360 DOI: 10.1016/j.humpath.2022.07.011] [Reference Citation Analysis]
|